Kadamkulam Syriac, Arun
Nandu, Nitish Singh
Clark, Allison
Tavallai, Mehrad
Jin, Dexter X.
Sokol, Ethan
McGregor, Kimberly
Ross, Jeffrey S.
Danziger, Natalie
Leone, Jose Pablo
Article History
Received: 28 March 2024
Accepted: 15 July 2024
First Online: 24 July 2024
Declarations
:
: Approval for this study, including a waiver of informed consent and a HIPAA waiver of authorization, was obtained from the Western Institutional Review Board (Protocol No. 20152817).
: Not applicable.
: AC, JSR, ND, ESS, and DXJ are employed by Foundation Medicine and are shareholders in Roche. KM and MT were previously employed by Foundation Medicine. JPL received research funding from Kazia Therapeutics and consulting honoraria from Minerva Biotechnologies. The remaining authors declare that they have no competing interests.